2006
DOI: 10.1016/j.yexcr.2006.01.025
|View full text |Cite
|
Sign up to set email alerts
|

The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

9
136
1
3

Year Published

2009
2009
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 138 publications
(149 citation statements)
references
References 58 publications
(79 reference statements)
9
136
1
3
Order By: Relevance
“…5,22,31 In contrast to these reports and this study Heideman et al 4 described high CAR expression in esophageal squamous epithelium employing immunohistochemistry. However, no information on CAR distribution within the esophageal epithelium is given.…”
Section: Discussioncontrasting
confidence: 76%
See 1 more Smart Citation
“…5,22,31 In contrast to these reports and this study Heideman et al 4 described high CAR expression in esophageal squamous epithelium employing immunohistochemistry. However, no information on CAR distribution within the esophageal epithelium is given.…”
Section: Discussioncontrasting
confidence: 76%
“…This may be of impact because restricted CAR immunopositivity has been seen previously and in this study within the basal layers. 5,31 Furthermore, the use of the antibody RmcB, derived from a mouse hybridoma cell line, may explain the diverging results.…”
Section: Discussionmentioning
confidence: 99%
“…18,26 Consistent with this finding, double immu-nofluorescence labeling experiments revealed a punctate co-localization of CAR with occludin and ZO-1 in the apical and basolateral contacts between the uroepithelial cells in the neonatal and adult bladders. Similarly, CAR was co-localized with occludin and ZO-1 in the mouse choroid plexus, collecting tubule epithelia, and hepatocytes, 11 suggesting that CAR interacts with occludin and ZO-1 at the TJs and adhesion between uroepithelial cells. 27 Thus, the expression of CAR in the underlying, as well as superficial, cells might be integrated as a part of the strategy for virus-mediated gene therapy in the bladder uroepithelium.…”
Section: Commentmentioning
confidence: 94%
“…The lack of an intracellular tail will result in the loss of targeting of CAR to the TJs, and differences in the tail ends between the 2 CAR isoforms (amino acid 340-365 in CAR-1; amino acid 340-352 in CAR-2) affects their subcellular localization. 10,11 Taking into account that CAR-2 mRNA was dominant in the mucosa of the adult bladders, CAR-2 might be recruited to the basolateral contacts, as well as the apical TJs, in the bladder uroepithelium. Currently, however, the differential subcellular localization of CAR isoforms in the bladder uroepithelium remains to be determined.…”
Section: Commentmentioning
confidence: 99%
See 1 more Smart Citation